New product license for pain killers top 265 last year

Domestic drug makers are still keen on the development of antipyretics, analgesics and anti-inflammatory agents (therapeutic category number: 114), even in midst of steep decline in newly approved medicines due to implementation of mandatory validation system.

According to the Korea Food and Drug Administration, Korean firms have focused on producing tonics, such as drinks, vitamins and othe...